DAB486IL-2 diphtheria fusion toxin targeted to the interleukin-2 receptor expressed by activated lymphocytes data

Data from a Phase I/II trial, previously announced, have been published in a peer-reviewed journal, Arthritis and

Read the full 175 word article

How to gain access

Continue reading with a
two-week free trial.